Clinical Trials Browser

OTHER × Triple Negative Breast Neoplasms × temsirolimus × Clear all

NCT00998036 2017-12-13

Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors

Phase 1 Completed

Breast Neoplasms, Triple Negative Breast Neoplasms